Imagine this scene: late at night, you're curled up on the sofa with the dog that has accompanied you for ten years. The vet has just delivered bad news—cancer. You stare at the ceiling, and a thought flashes through your mind: what if... what if I could design a treatment plan for it?
It sounds like science fiction, but on March 28, 2026, this scenario actually happened.
How the Story Began
Paul Conyngham is an ordinary AI user. When his dog was diagnosed with cancer, instead of giving up, he opened a familiar interface—ChatGPT.
Yes, the same ChatGPT you use to type questions on your phone.
Paul began conversations with the AI, asking about mRNA vaccines, the principles of cancer immunotherapy, and how to design personalized treatment approaches. Like a diligent student guided by a patient mentor, he worked through complex biomedical concepts step by step.
Eventually, Paul designed a personalized vaccine plan based on mRNA technology. Whether it ultimately cured his dog, we don't know. But when Sam Altman shared the story, the discussion it sparked went far beyond the fate of one dog.
Why mRNA?
To understand the significance of this story, we first need to know what mRNA vaccines are.
Think of your body as a city, and viruses or cancer cells as invaders. Traditional vaccines are like wanted posters issued to the city—letting the body recognize the enemy in advance. mRNA vaccines are different: they're like handing the city an "instruction manual for building the invader." Your body reads the instructions, produces the enemy's "signature fragments" itself, and then mounts a targeted defense.
The beauty of this technology is its flexibility. Traditional vaccine production requires culturing viruses, inactivation, and purification—a process that can take months. mRNA vaccines only need the gene sequence of the target protein and can be designed and produced within weeks.
That's the key to why Paul could "design" a plan—he didn't need a lab or cell cultures. He only needed knowledge and imagination.
What Role Did AI Play?
Some might ask: did AI do anything special? Isn't all this information already online?
Yes, the information is online. But the ocean of information is chaotic. Imagine walking into a library where the shelves stretch from floor to ceiling, every book about cancer treatment. Where do you even start?
AI acted as the guide in that library. It helped Paul:
- Filter core concepts related to mRNA vaccines from a massive amount of information
- Translate obscure medical terminology into understandable language
- Organize the pros and cons of different treatment strategies
- Build a logically coherent framework for the plan
- Sam Altman sharing the original post: https://x.com/sama/status/1895206925259778440
This is not simple information retrieval—it is the structuring and re-creation of knowledge.
The Deeper Meaning: A Regulatory Gap and an Innovation Lab
The most interesting part of this story may not be the technology itself, but where it took place.
In human medicine, mRNA vaccine development is strictly regulated. Clinical trials, approval processes, safety assessments—every step takes years and enormous funding. This system protects human safety, but it also slows innovation.
In veterinary medicine, regulation is relatively lax. Paul didn't need FDA approval or ethics committee permission; he could directly test his ideas.
This reveals an interesting paradox: sometimes, fields with fewer restrictions become the testing grounds for cutting-edge technology.
Consider another angle: if Paul's plan succeeded, it might not only save his dog but also provide valuable experiential data for human medicine. Veterinary medicine becomes a "sandbox environment" for personalized medicine—a place where ideas can be validated quickly and successes replicated quickly.
The Feynman Moment: Explaining It in One Sentence
If Richard Feynman were still alive, he might explain it like this:
"Imagine your dog is sick, and you have two choices: wait for the doctor's standard protocol, or learn enough to design a customized plan yourself. AI makes the second option possible—it compresses knowledge that once required ten years of medical education into a few evenings of conversation."
Imagining the Future
Paul's story is an isolated case, but it points to a possible future.
In that future, when someone is diagnosed with a rare disease, a doctor might work with AI to design a personalized treatment plan based on the patient's genotype within hours. The plan might combine mRNA technology, immunotherapy, and targeted drugs—all components "tailor-made."
Of course, this still requires substantial technological maturation and regulatory development. But Paul and his dog have already taken the first step.
---
Related links: